Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment
Balance (in shares) at Dec. 31, 2020			95,456,862
Balance at Dec. 31, 2020	$ 94,071		$ 95	$ 395,347		$ 9,371	$ (310,742)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Common stock in connection with follow-on offering, net of issuance costs of $17,466 (in shares)			7,961,538
Issuance of Common stock in connection with follow-on offering, net of issuance costs of $17,466	500,034		$ 8	500,026
Stock-based compensation expense	109,779			109,779
Common stock issued under employee stock plans (shares)			4,090,696
Common stock issued under employee stock plans	13,902		$ 5	13,897
Taxes paid related to net share settlement of equity awards	(1,044)			(1,044)
Realized and unrealized income (loss) on derivative	(3,285)					(3,285)
Unrealized income (loss) on available for sale securities, net of tax	(3)					(3)
Net loss	(116,861)						(116,861)
Balance (in shares) at Dec. 31, 2021			107,509,096
Balance at Dec. 31, 2021	$ 596,593	$ (22,147)	$ 108	1,018,005	$ (30,794)	6,083	(427,603)	$ 8,647
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06 [Member]
Stock-based compensation expense	$ 142,862			142,862
Common stock issued under employee stock plans (shares)			3,078,402
Common stock issued under employee stock plans	12,496		$ 3	12,493
Taxes paid related to net share settlement of equity awards	(31,076)			(31,076)
Repurchase of common stock (in shares)			(2,914,446)
Repurchase of common stock	(56,445)		$ (3)	(56,442)
Realized and unrealized income (loss) on derivative	(15,363)					(15,363)
Unrealized income (loss) on available for sale securities, net of tax	(277)					(277)
Net loss	(124,518)						(124,518)
Balance (in shares) at Dec. 31, 2022			107,673,052
Balance at Dec. 31, 2022	502,125		$ 108	1,055,048		(9,557)	(543,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	139,819			139,819
Common stock issued under employee stock plans (shares)			2,931,316
Common stock issued under employee stock plans	12,649		$ 2	12,647
Taxes paid related to net share settlement of equity awards	(21,415)			(21,415)
Repurchase of common stock (in shares)			(1,500,647)
Repurchase of common stock	(43,522)		$ (1)	(43,521)
Realized and unrealized income (loss) on derivative	(1,040)					(1,040)
Unrealized income (loss) on available for sale securities, net of tax	1,948					1,948
Net loss	(100,916)						(100,916)
Balance (in shares) at Dec. 31, 2023			109,103,721
Balance at Dec. 31, 2023	$ 489,648		$ 109	$ 1,142,578		$ (8,649)	$ (644,390)